Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Thomas Scadden, M.D.

Co-Author

This page shows the publications co-authored by David Scadden and Ralph Weissleder.
Connection Strength

0.210
  1. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol. 2000 Apr; 18(4):410-4.
    View in: PubMed
    Score: 0.056
  2. Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science. 2017 12 01; 358(6367).
    View in: PubMed
    Score: 0.048
  3. Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells. Cell Stem Cell. 2015 May 07; 16(5):477-87.
    View in: PubMed
    Score: 0.040
  4. Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res. 2015 Jan 30; 116(3):407-17.
    View in: PubMed
    Score: 0.039
  5. Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc Natl Acad Sci U S A. 2010 Mar 16; 107(11):5124-9.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.